Plutonium Biokinetics in Human Body A. Luciani - Kit-Bibliothek - FZK
Plutonium Biokinetics in Human Body A. Luciani - Kit-Bibliothek - FZK
Plutonium Biokinetics in Human Body A. Luciani - Kit-Bibliothek - FZK
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
For the rout<strong>in</strong>e application of Model-b <strong>in</strong> the radiation protection practice, the E(50)<br />
coefficients for a subject of age 40 at the moment of the <strong>in</strong>take can be assumed as base case<br />
values for two ma<strong>in</strong> reasons:<br />
1. The E(50) coefficients are only slightly dependent on the age of the subject;<br />
2. A subject aged forty is represent<strong>in</strong>g the mean age of workers.<br />
The ma<strong>in</strong> contributions from organs and tissues to the E(50) coefficients for a 40 years<br />
old subject were calculated as well (Table 3.1.16) <strong>in</strong> terms of organ or tissue equivalent dose,<br />
H T (see Annex). The values are compared with the same values us<strong>in</strong>g the ICRP 67 model, <strong>in</strong><br />
order to evaluate the effect of the modification <strong>in</strong> dosimetric terms <strong>in</strong>troduced by the new<br />
model. The equivalent dose to the lung is also given, because it can significantly contribute to<br />
the E(50), particularly <strong>in</strong> case of absorption type S. No difference <strong>in</strong> lung equivalent dose is<br />
expected because it just depends on the respiratory tract model. From Table 3.1.16 it can be<br />
seen that Model-b, on average for all the standard scenarios of contam<strong>in</strong>ation, predicts higher<br />
equivalent doses for the bone marrow (+35%,) and smaller ones for the bone surfaces and the<br />
liver (–7% and –12%, respectively) than does ICRP 67. The previous considerations relat<strong>in</strong>g<br />
to 239 Pu can also be applied to the other <strong>Plutonium</strong> radioisotopes.<br />
E(50) coefficients for a forty years old subject <strong>in</strong> case of <strong>in</strong>halation and <strong>in</strong>gestion of<br />
the ma<strong>in</strong> <strong>Plutonium</strong> radioisotopes are f<strong>in</strong>ally given <strong>in</strong> Table 3.1.17 for standard conditions of<br />
exposure. They were partially already published <strong>in</strong> a recent publication [163]. These<br />
coefficients can be directly applied <strong>in</strong> the practical radiation protection procedures.<br />
Table 3.1.16 The ma<strong>in</strong> contributions from organs and tissues to the E(50) coefficients for a<br />
forty years old subject <strong>in</strong> term of organ or tissue equivalent dose (H T(50)).<br />
Scenario:<br />
AMAD–Type<br />
or f 1<br />
Inhalation<br />
117<br />
Organ or tissue<br />
Bone Marrow Bone Surfaces Liver Lung<br />
Model-b.<br />
1 µm - M 9.6•10 -5<br />
1 µm - S 1.1•10 -5<br />
5 µm - M 6.6•10 -5<br />
5 µm - S 6.0•10 -6<br />
Ingestion<br />
5•10 -4<br />
1•10 -4<br />
1•10 -5<br />
5.4•10 -7<br />
1.1•10 -7<br />
1.1•10 -8<br />
ICRP67<br />
7.1•10 -5<br />
8.6•10 -6<br />
4.9•10 -5<br />
4.6•10 -6<br />
4.0•10 -7<br />
8.1•10 -8<br />
8.6•10 -9<br />
Model-b.<br />
1.4•10 -3<br />
1.6•10 -4<br />
9.7•10 -4<br />
8.5•10 -5<br />
7.9•10 -6<br />
1.6•10 -6<br />
1.6•10 -7<br />
ICRP67<br />
1.5•10 -3<br />
1.7•10 -4<br />
1.0•10 -3<br />
9.1•10 -5<br />
8.2•10 -6<br />
1.7•10 -6<br />
1.7•10 -7<br />
Model-b.<br />
2.7•10 -4<br />
3.2•10 -5<br />
1.9•10 -4<br />
1.7•10 -5<br />
1.5•10 -6<br />
3.0•10 -7<br />
3.1•10 -8<br />
ICRP67<br />
3.1•10 -4<br />
3.6•10 -5<br />
2.1•10 -4<br />
1.9•10 -5<br />
1.7•10 -6<br />
3.5•10 -8<br />
3.5•10 -8<br />
Model-b.<br />
2.8•10 -5<br />
7.9•10 -5<br />
1.9•10 -5<br />
4.7•10 -5<br />
~0<br />
~0<br />
~0<br />
ICRP67<br />
2.8•10 -5<br />
7.9•10 -5<br />
1.9•10 -5<br />
4.7•10 -5<br />
~0<br />
~0<br />
~0